Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Share This Post

Alzheimer's / Childhood Epilepsy / Community / Education / Epilepsy / Media / Medicine / Memory / Migraine / Parents / Prevention / Research / Seizures / Social Media / Surgery / Technology / Treatment / Women and Epilepsy

Genes May Play Greater Role in Focal Epilepsy than Previously Thought

Genes May Play Greater Role in Focal Epilepsy than Previously Thought

3d-brainAlthough focal epilepsies generally have not been considered to be genetic disorders, an international team led by researchers from the University of South Australia in Adelaide has uncovered evidence that a genetic component indeed exists.

After identifying an association between DEPDC5gene mutations and familial focal epilepsy,1 the researchers turned their sights to the DEPDC5’sGATOR1 protein complex partners, a master regulator of cell growth and metabolism and the mechanistic target of rapamycin (mTOR) regulators NPRL2 and NPRL3, and found associations between mutations in them and focal epilepsy.2

The researchers reasoned that if DEPDC5 mutations result in hyperactivity of mTOR signaling, then mutations in other genes that bind with it to form the GATOR 1 protein complex—namelyNPRL2 and NPRL3— also may be implicated. The research team, led by Leanne Dibbens, PhD, an associate research professor and head of the Epilepsy Genetics Research Group at the School of Pharmacy and Medical Sciences, University of South Australia, demonstrated previously and through this current study that mutations in the GATOR1 complex are the most significant genetic cause of focal epilepsy and contribute to pathology via dysregulation of cell growth.1,2

The researchers used a custom gene sequencing panel to identify NPRL2 and NPRL3 mutations in 404 unrelated probands with focal epilepsy and performed exome sequencing on 2 families in which multiple members had focal epilepsy.  In addition, the researchers also analyzed DEPDC5 in the 404 probands. Of the total study population, more than half (239 [59%]) had temporal lobe epilepsy and 91 (23%) had nocturnal frontal lobe epilepsy. Frontal (7%), occipital (4%), or parietal lobe epilepsy (1%); benign epilepsy with centrotemporal spikes/rolandic epilepsy (4%); focal epilepsy associated with structural brain lesions (1%); and focal epilepsy and developmental delay (<1%) were documented in the remainder. A total of 272 cases were familial and 132 were sporadic. All study participants were negative for KCNT1 mutations and none of the participants with nocturnal frontal lobe epilepsy harbored mutations in CHRNA2, CHRNB2, and or CHRNA4.

The team discovered 5 mutations each in NPRL2(4 familial and 1 sporadic) and NPRL3 (all familial) and 18 new mutations in DEPDC5 (17 familial and 1 sporadic). Exome sequencing analysis implicated NPRL2 and NPRL3 as the primary candidates underlying familial focal epilepsy among the 2 families studied.

Focal epilepsy–associated brain malformations, identified in 4 persons among the 404 study participants, were likely attributed to increased mTOR-activity resulting from the GATOR1 mutations, according to the researchers. Among the 4 cases were 2 that were sporadic but found to have a GATOR1 gene mutation: one was a case of frontal lobe epilepsy with a tumor-like brain lesion and the other a case of focal epilepsy with a bilateral brain malformation. The researchers surmised that dysregulation of mTOR-mediated control of cell growth causes patches of irregular growth that, in turn, disrupt neural circuitry, resulting in epilepsy. As for persons with focal epilepsy in whom brain lesions are not detected, further study into cryptogenic GATOR1 gene-related anatomical alterations in cell growth may be in order, the researchers said.

In all, the findings suggest that defective mTOR signaling and dysregulation of cell growth during brain development may play a greater role in focal epilepsy than has been recognized. In their forward-looking conclusion, the study authors said that further research may provide new avenues for therapeutic research, such as the prospect of mTOR inhibitors.


  1. Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45(5):546-551.
  2. Ricos MG, Hodgson BL, Pippucci T, et al. Mutations in the mTOR pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol. 2015; doi:10.1002/ana.24547.

SOURCE: http://www.neurologyadvisor.com/epilepsy/focal-epilepsy-pathology-genetic-mutation/article/452601/2/

Share This Post


  1. Dawn Marie, #SourayaFaas, Michelle Singer Pierce, Michelle Herrera Norori, Vicky Ruiz-Rosario, William Ahlmark, Heather Herzog Harris, Jennie Glinsky Bernstein, Juan Segovia, Juan R. Peralta, Rosanna Molinari Weber, Rosa Price, Elizabeth Scafuti Vodré, Elizabeth Ramirez, Gerald Little, Giovanna Jimenez Russell, Jeffrey Taraboulos, Krista Russo Chern, Al Picon, Bridgette Bonilla Alfonso, Dona Marie Uva, Carl Stout, Chandra Irving Geschwill, Hector Avila, Rory Diaz, Rick Castillo, Albert Machado, Nolan Acierto, Patty Brumfield-Thompson, Patty Holman, Kim McKee Staples, Shea Polakow, Sherri Weisberg Feldman, Sherry Hughes

  2. Our epilepsy is genetic.

  3. this is the best picture i have ever seen to show where the different parts of the brain are so i can pin point where my dr said my seizures are located. thanks.

Comments are now closed for this post.